IHT for Mild Cognitive Impairment
This phase I clinical trial will examine the safety and efficacy of intermittent hypoxia training (IHT) for up to 12 weeks to treat subjects with mild cognitive impairment (MCI).
Adult men and women ages 55 to 79 years old who have been diagnosed with MCI. [+7]
Unwilling to sign a written consent to participate in this double-blinded placeb... [+10]